Posts by: Leonor Mateus Ferreira

Leonor Mateus Ferreira

Leonor Mateus Ferreira is an emerging, young journalist, with a Batchelor's degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.

December 4, 2015December 3, 2015

Array, Pierre Fabre to Collaborate on New Melanoma Drugs

News

Array BioPharma Inc., based in Colorado, and Pierre Fabre of France have recently announced they will collaborate on the development and commercialization of novel oncology products for the treatment of melanoma and ovarian ... Read more

June 15, 2015June 15, 2015

Majority of US Population Does Not Use Sunscreen

News

According to a recent study led by the Centers for Disease Control and Prevention (CDC) and published in the Journal of the American Academy of Dermatology, most people in the United States do not regularly ... Read more

May 20, 2015May 20, 2015

Genentech to Present Melanoma Therapy at ASCO Meeting

Melanoma, News

Genentech, a biopharmaceutical firm that is part of the Roche Group, will present over 275 abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place between May 29th ... Read more

May 15, 2015May 15, 2015

Provectus’ Synthesis Patent Granted by Europe and Japan

Melanoma, News

Clinical-stage dermatology company Provectus Biopharmaceuticals, which works in the fields of oncology and dermatology, has been granted allowance of its patent application from both the European Patent Office and the Japanese ... Read more

April 20, 2015April 20, 2015

Study Shows Advertising Influences Tanning Behavior

Melanoma, News

Advertising and magazines that present tanning on a beach as a paradise in exotic vacation destinations with smiling, tanned models may be influencing people to search out ways of getting more tanned, ... Read more

March 10, 2015April 21, 2015

FTC to Pursue Charges Against Melanoma Detection Apps

Melanoma, News

The Federal Trade Commission (FTC) has opened a case to end fraudulent advertisement regarding mobile apps that are supposed to diagnose melanoma through detecting symptoms or pictures of moles. While two marketers, MelApp ... Read more

March 3, 2015March 3, 2015

CURE OM Encourages Ocular Melanoma Patients to Share Stories

Melanoma, News

The Melanoma Research Foundation‘s Community United for Research and Education of Ocular Melanoma (CURE OM) program recently commended Oliver Sacks, a patient with ocular melanoma (OM), for sharing his experiences with the disease in ... Read more

February 24, 2015February 24, 2015

Singaporean Institute Launches Personalized Cancer System for Melanoma, Other Disease Types

News

The Agency for Science, Technology and Research (A*STAR)’s Genome Institute of Singapore (GIS) is launching a novel system able to connect large databases and integrate complex information in order to support ... Read more

January 6, 2015January 6, 2015

Indoor Tanning Decreases Among U.S. High School Students But Still Concerning

News

According to recent research from the U.S. Centers for Disease Control and Prevention, the trend in indoor tanning among high school students is on the decline. However, white females remain the demographic with the highest ... Read more

September 26, 2014September 26, 2014

Deployed Military Have Higher Risk of Developing Skin Cancer

News

Soldiers who are deployed into locations with tropical and sunny climates are returning to the United States with a higher risk of developing skin cancer, as concluded by a retrospective ... Read more

September 24, 2014September 24, 2014

Telomeres Length May Influence Risk of Developing Melanoma

Melanoma, News

People who have longer telomeres, a compound structure at the end of a chromosome, have higher risk of suffering from melanoma, according to the study “The effect on melanoma risk of ... Read more

September 22, 2014September 22, 2014

Decision Resources Group Survey Shows that Half of Oncologists Prescribe Tafinlar and Mekinist to Treat Melanoma

Melanoma, News

The consulting company Decision Resources Group, which analyzes critical issues within the healthcare industry, recently concluded that more than half of the surveyed U.S. oncologists prescribe GlaxoSmithKline‘s BRAF inhibitor Tafinlar for BRAF-mutation-positive unresectable or ... Read more

September 11, 2014September 11, 2014

Myriad myPath Melanoma Reduces Indeterminate Diagnosis and May Correct Treatment Recommendations

Melanoma, News

Molecular diagnostic company Myriad Genetics recently presented the results of its pivotal clinical utility study of the Myriad myPath Melanoma test, a new diagnostic tool for determining if a tissue is a malignant melanoma or ... Read more

September 9, 2014September 9, 2014

JAMA Dermatology Advocates Changes in Healthcare Melanoma Screening

Melanoma, News

The monthly peer-reviewed medical journal published by the American Medical Association recently advocated changes to the way the nation’s melanoma screens are performed within the healthcare system, considering that there is $2.85 billion in overall lost productivity to the entire economy, in ... Read more

August 26, 2014August 26, 2014

Merck’s Immuno-Oncology Melanoma Drug May Be On Track For FDA Approval

Melanoma, News

Merck & Co‘s novel immuno-oncology drug for melanoma, pembrolizumab, is about to be approved by the U.S. Food and Drug Administration, according to a news report released yesterday by Reuters, ... Read more

August 25, 2014August 25, 2014

Teenagers Wear Less Sunscreen and Still Use Indoor Tanning In Spite of Skin Cancer Risks

News, Skin Cancer

Fewer teenagers wear sunscreen when exposed to the sun, and the rate of indoor tanning has hardly changed, according to a recent study conducted at William Paterson University in New Jersey and ... Read more

July 30, 2014July 30, 2014

Roche Announces Effectiveness and Safety of Novel Combination Drug Treatment for Melanoma

Melanoma, News

Swiss biotech company Roche has announced the development of a skin cancer medication treatment that has shown in a late-stage test to be effective in helping advanced patients live longer without disease ... Read more

July 25, 2014July 25, 2014

Senate Appropriations Committee Doubles Cancer Research Funding, Emphasizes Melanoma

Melanoma, News

The Senate Appropriations Committee recently approved the fiscal year 2015 Defense Appropriations bill, earmarking $50 million for the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program (PRCRP) — a doubling of ... Read more